Presently, Ching Yau Yi occupies the position of Chief Accounting Officer & Senior VP-Finance at ChemoCentryx, Inc. and Chief Accounting Officer of BridgeBio Pharma, Inc.

In the past she occupied the position of Vice President-Finance of Nektar Therapeutics, Controller of Theravance Biopharma, Inc. and Senior Manager at Ernst & Young LLP.

Ms. Yi received an undergraduate degree from Nanyang Technological University.